VIVA and The VEINS 2026 will spotlight a dynamic series of Late-Breaking Clinical Trial presentations, showcasing cutting-edge research and pivotal data for vascular specialists. These sessions provide early insights into major randomized trials, long-term registry results, and first-in-human experiences with innovative devices and therapies.
Each presentation will be followed by an interactive discussion and audience Q&A, led by a panel of renowned experts. Don’t miss your chance to contribute to the conversation driving the next era of vascular innovation.
The 2026 abstract submission portal will open May 7 at 12pm PT.
VIVA and The VEINS embargo Late-Breaking Clinical Trial information from becoming public until after the commencement of the session as listed in the conference program or on viva-foundation.org. No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented.
Abstracts will be evaluated and scored based on the following criteria:
Submission Deadline: July 9
The review committee may determine that your abstract may be more appropriate for a different session or conference than you originally submitted.
If you have questions please contact Brita Thorne via e-mail: abstracts@viva-foundation.org
